A Review Of Hemgenix
Variety of qualified individuals: CDEC talked about the uncertainty in the quantity of people with moderately severe to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific specialists consulted by CADTH indicated that some individuals who are classified as having mild or moderate disease can have a intense bleeding phe